Demographic and geographic features of exfoliation glaucoma in 2 United States-based prospective cohorts

Ophthalmology

Volumn 119, Issue 1, 2012, Pages 27-35

  Kang, Jae Hee ^a   Loomis, Stephanie ^b   Wiggs, Janey L ^b   Stein, Joshua D ^c   Pasquale, Louis R ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; EXFOLIATION GLAUCOMA SUSPECT; EXFOLIATION SYNDROME; EYE EXAMINATION; FEMALE; FOLLOW UP; GENDER; GEOGRAPHY; HEALTH PRACTITIONER; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RISK; UNITED STATES;

ADULT; AGE FACTORS; AGED; BODY CONSTITUTION; CONTINENTAL POPULATION GROUPS; EXFOLIATION SYNDROME; EYE COLOR; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; GEOGRAPHY; GLAUCOMA; HEALTH PERSONNEL; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 84855331106     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.06.018     Document Type: Article

References (50)

1. Ritch R. The management of exfoliative glaucoma. Prog Brain Res 2008;173:211-24.
2. Puska P, Tarkkanen A. Exfoliation syndrome as a risk factor for cataract development: five-year follow-up of lens opacities in exfoliation syndrome. J Cataract Refract Surg 2001;27:1992-8. (Pubitemid 33136181)
3. Saatci OA, Ferliel ST, Ferliel M, et al. Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion. Int Ophthalmol 1999;23:75-8. (Pubitemid 32041062)
4. Cursiefen C, Hammer T, Kuchle M, et al. Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion: a histopathologic and electron microscopic study. Acta Ophthalmol Scand 2001;79:476-8. (Pubitemid 32962837)
5. Gillies WE, Brooks AM. Central retinal vein occlusion in pseudoexfoliation of the lens capsule. Clin Experiment Ophthalmol 2002;30:176-87.
6. Ritch R, Prata TS, de Moraes CG, et al. Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis. Acta Ophthalmol 2010;88:91-5.
7. Naumann GO, Erlanger-Augenblatter-Group. Exfoliation syndrome as a risk factor for vitreous loss in extracapsular cataract surgery (preliminary report). Acta Ophthalmol Suppl 1988;66(S184):129-31.
8. Scorolli L, Scorolli L, Campos EC, et al. Pseudoexfoliation syndrome: a cohort study on intraoperative complications in cataract surgery. Ophthalmologica 1998;212:278-80. (Pubitemid 28293624)
9. Shingleton BJ, Heltzer J, O'Donoghue MW. Outcomes of phacoemulsification in patients with and without pseudoexfoliation syndrome. J Cataract Refract Surg 2003;29:1080-6. (Pubitemid 36759096)
10. Abela-Formanek C, Amon M, Schauersberger J, et al. Uveal and capsular biocompatibility of 2 foldable acrylic intraocular lenses in patients with uveitis or pseudoexfoliation syndrome: comparison to a control group. J Cataract Refract Surg 2002;28:1160-72. (Pubitemid 34774207)
11. Lindberg J. Kliniska Undersokningar over Depigmentering av Pupillarranden och Genomlsybarhet av Iris vid Fall av Aldersstarr samt i Normala Ogon hos Gamla Personer [thesis]. Helsingfors, Finland: University of Helsinki; 1917.
12. Eagle RC Jr, Font RL, Fine BS. The basement membrane exfoliation syndrome. Arch Ophthalmol 1979;97:510-5. (Pubitemid 9098746)
13. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007;317:1397-400. (Pubitemid 47417481)
14. Forsman E, Cantor RM, Lu A, et al. Exfoliation syndrome: prevalence and inheritance in a subisolate of the Finnish population. Acta Ophthalmol Scand 2007;85:500-7. (Pubitemid 47163111)
15. Astrom S, Stenlund H, Linden C. Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up. Acta Ophthalmol Scand 2007;85:832-7. (Pubitemid 350142804)
16. Krause U, Alanko HI, Karna J, et al. Prevalence of exfoliation syndrome in Finland. Acta Ophthalmol Suppl 1988;66(S184):120-2.
17. Hewitt AW, Sharma S, Burdon KP, et al. Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet 2008;17:710-6. (Pubitemid 351292259)
18. McCarty CA, Taylor HR. Pseudoexfoliation syndrome in Australian adults. Am J Ophthalmol 2000;129:629-33. (Pubitemid 30323729)
19. Topouzis F, Wilson MR, Harris A, et al. Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study. Am J Ophthalmol 2007;144:511-9.
20. Rao RQ, Arain TM, Ahad MA. The prevalence of pseudoexfoliation syndrome in Pakistan: hospital based study. BMC Ophthalmol [serial online] 2006;6:27. Available at: http://www.biomedcentral.com/1471-2415/6/27. Accessed June 3, 2011.
21. Colin J, Le Gall G, Le Jeune B, Cambrai MD. The prevalence of exfoliation syndrome in different areas of France. Acta Ophthalmol Suppl 1988;66(S184):86-9.
22. Rudkin AK, Edussuriya K, Sennanayake S, et al. Prevalence of exfoliation syndrome in central Sri Lanka: the Kandy Eye Study. Br J Ophthalmol 2008;92:1595-8.
23. Young AL, Tang WW, Lam DS. The prevalence of pseudoexfoliation syndrome in Chinese people. Br J Ophthalmol 2004;88:193-5. (Pubitemid 38142084)
24. Arvind H, Raju P, Paul PG, et al. Pseudoexfoliation in South India. Br J Ophthalmol 2003;87:1321-3. (Pubitemid 37452551)
25. Stein JD, Pasquale LR, Talwar N, et al. Geographic and climatic factors associated with the exfoliation syndrome. Arch Ophthalmol 2011;129:1053-60.
26. Hernan MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999;53:1711-8. (Pubitemid 29530344)
27. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall; 1984:1-201.
28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
29. Karger RA, Jeng SM, Johnson DH, et al. Estimated incidence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Olmsted County, Minnesota. J Glaucoma 2003;12:193-7. (Pubitemid 36736718)
30. Arnarsson A, Damji KF, Sasaki H, et al. Pseudoexfoliation in the Reykjavik Eye Study: five-year incidence and changes in related ophthalmologic variables. Am J Ophthalmol 2009;148:291-7.
31. Kang JH, Wiggs JL, Rosner BA, et al. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with gender and postmenopausal hormone use. Invest Ophthalmol Vis Sci 2010;51:971-9.
32. Jones W, White RE, Magnus DE. Increased occurrence of exfoliation in the male, Spanish American population of New Mexico. J Am Optom Assoc 1992;63:643-8.
33. Forsius H, Forsman E, Fellman J, Eriksson AW. Exfoliation syndrome: frequency, gender distribution and association with climatically induced alterations of the cornea and conjunctiva. Acta Ophthalmol Scand 2002;80:478-84. (Pubitemid 35243851)
34. Ringvold A, Blika S, Elsas T, et al. The Middle-Norway eye-screening study. I. Epidemiology of the pseudo-exfoliation syndrome. Acta Ophthalmol (Copenh) 1988;66:652-8. (Pubitemid 19064114)
35. Jonasson F, Damji KF, Arnarsson A, et al. Prevalence of open-angle glaucoma in Iceland: Reykjavik Eye Study. Eye (Lond) 2003;17:747-53. (Pubitemid 37120968)
36. Orzalesi N, Aschero M, Autelitano A. Epidemiology of pseudoexfoliation. New Trends Ophthalmol 1993;8:131-4. (Pubitemid 24019775)
37. Ball SF. Exfoliation syndrome prevalence in the glaucoma population of South Louisiana. Acta Ophthalmol Suppl 1988;66(S184):93-8.
38. Rotchford AP, Kirwan JF, Johnson GJ, Roux P. Exfoliation syndrome in black South Africans. Arch Ophthalmol 2003;121:863-70. (Pubitemid 36676225)
39. Bartholomew RS. Pseudocapsular exfoliation in the Bantu of South Africa. II. Occurrence and prevalence. Br J Ophthalmol 1973;57:41-5.
40. Miyazaki M, Kubota T, Kubo M, et al. The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama study. J Glaucoma 2005;14:482-4. (Pubitemid 41682243)
41. Lamba PA, Giridhar A. Pseudoexfoliation syndrome (prevalence based on random survey hospital data). Indian J Ophthalmol 1984;32:169-73.
42. Thomas R, Nirmalan PK, Krishnaiah S. Pseudoexfoliation in southern India: the Andhra Pradesh Eye Disease Study. Invest Ophthalmol Vis Sci 2005;46:1170-6. (Pubitemid 41685849)
43. Arnarsson A, Jonasson F, Damji KF, et al. Exfoliation syndrome in the Reykjavik Eye Study: risk factors for baseline prevalence and 5-year incidence. Br J Ophthalmol 2010;94:831-5.
44. Arnarsson AM. Epidemiology of exfoliation syndrome in the Reykjavik Eye Study [dissertation]. Reykjavik, Iceland: University of Iceland; Acta Ophthalmol 2009;87:1-17.
45. Cashwell LF Jr, Shields MB. Exfoliation syndrome: prevalence in a southeastern United States population. Arch Ophthalmol 1988;106:335-6. (Pubitemid 18081712)
46. Abdul-Rahman AM, Casson RJ, Newland HS, et al. Pseudoexfoliation in a rural Burmese population: the Meiktila Eye Study. Br J Ophthalmol 2008;92:1325-8.
47. Galambos P, Vafiadis J, Vilchez SE, et al. Compromised autoregulatory control of ocular hemodynamics in glaucoma patients after postural change. Ophthalmology 2006;113:1832-6. (Pubitemid 44442446)
48. Kozobolis VP, Papatzanaki M, Vlachonikolis IG, et al. Epidemiology of pseudoexfoliation in the island of Crete (Greece). Acta Ophthalmol Scand 1997;75:726-9. (Pubitemid 28102749)
49. Astrom S, Linden C. Incidence and prevalence of pseudoexfoliation and open-angle glaucoma in northernSweden: I. Baseline report. Acta Ophthalmol Scand 2007;85:828-31. (Pubitemid 350142803)
50. Mitchell P, Wang JJ, Hourihan F. The relationship between glaucoma and pseudoexfoliation: the Blue Mountains Eye Study. Arch Ophthalmol 1999;117:1319-24. (Pubitemid 30029342)